Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma

Cancer

Volumn 112, Issue 7, 2008, Pages 1480-1488

  Margulis, Vitaly ^a   Tamboli, Pheroze ^a   Matin, Surena F ^a   Swanson, David A ^a   Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer specific survival; Lymph node metastases; Papillary renal cell carcinoma; Radical nephrectomy; Venous tumor thrombus

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL PROTOCOL; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PAPILLARY CARCINOMA; PARTIAL NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REFERENCE DATABASE; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION; TUMOR THROMBUS;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41149090291     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23322     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Kovacs G. Molecular differential pathology of renal cell tumours. Histopathology. 1993;22:1-8.
3. Bugert P, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol. 1996;149:2081-2088.
4. Furge KA, Lucas KA, Takahashi M, et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res. 2004;64:4117-4121.
5. Takahashi M, Yang XJ, Sugimura J, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene. 2003;22:6810-6818.
6. Eble JN; World Health Organization. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon & Oxford: IARC Press & Oxford University Press; 2004.
7. Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281-291.
8. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624.
9. Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11:71-77.
10. Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763-2771.
11. Ficarra V, Martignoni G, Galfano A, et al. Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol. 2006;50:786-793; discussion 793-794.
12. Ljungberg B, Alamdari FI, Stenling R, Roos G. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol. 1999;36:565-569.
13. Greene FL; American Joint Committee on Cancer; American Cancer Society. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
14. Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002;20:2376-2381.
15. Ronnen EA, Kondagunta GV, Ishill N, et al. Treatment outcome for metastatic papillary renal cell carcinoma patients. Cancer. 2006;107:2617-2621.
16. Herrmann E, Brinkmann OA, Bode ME, et al. Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil. Eur Urol. 2007;51:1625-1631; discussion 1631-1632.
17. Drucker BJ, Mazumdar M, Motzer RJ. Prognostic factors for metastatic kidney cancer. Cancer Treat Res. 2003;116:139-153.
18. Kassouf W, Sanchez-Ortiz R, Tamboli P, et al. Cytoreductive nephrectomy for metastatic renal cell carcinoma with non-clear cell histology. J Urol. 2007;178:1896-1900.
19. Motzer RJ, Bacik J, Mazumdar M. Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer Center experience. Clin Cancer Res. 2004;10(18 pt 2):6302S-6303S.
20. Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol. 2004;172:465-469.